FDA approves Alzheimer’s drug lecanemab amid safety concerns
FDA approves Alzheimer’s drug lecanemab amid safety concerns
About this item
Full title
FDA approves Alzheimer’s drug lecanemab amid safety concerns
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Nature (London), 2023-01, Vol.613 (7943), p.227-228
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Reports of deaths potentially linked to the treatment have cast a shadow on what many hail as a landmark approval.
Reports of deaths potentially linked to the treatment have cast a shadow on what many hail as a landmark approval.
Alternative Titles
Full title
FDA approves Alzheimer’s drug lecanemab amid safety concerns
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_springer_journals_10_1038_d41586_023_00030_3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_springer_journals_10_1038_d41586_023_00030_3
Other Identifiers
ISSN
0028-0836
E-ISSN
1476-4687
DOI
10.1038/d41586-023-00030-3
How to access this item
Log in as a Library member
